www.COVIPOCUSWORLD.com
24th
January 2021
The Fourth session of COVIPOCUS2021 was held on 23rd
January 2021 from 6:30PM- 9:30PM (India Time). Delegates from all over the
world participated in the conference. The meeting was also attended by 10
international leaders.
Key-Note
Session
Speakers:
Dr.
Christopher Fung from Michigan University Emergency Medicine Residency Program
Dr.
Fung discussed about the various expanded uses of POCUS and current literature and
recommendation for its use with patients with COVID19.
Prof.
Prabath Nanayakkara from Netherlands and The Founder Member of The World
Academic Council of Emergency Medicine.
Prof.
Prabath discussed about creating the infrastructure for Randomized Control
Trials in POCUS.
Special
Session of Phase Zero Trials Team
A
special presentation was done by Mr. Kevin Lee from Phase Zero Trials
where we discussed about Image Driven RCT in POCUS and how latest technologies
could bank and analyze the volumes of data being gathered from across the
world.
Open
House Discussion:
A
Very vibrant discussion was held on various factors related to variability,
bias and anthropology when collecting POCUS data across the world.
Dr.
Vali (Tanzania) Dr. Fung (USA), Dr. Prabath (Netherlands) led the discussions.
Countries
such as Turkey, Japan, France, South America, Spain and a few others have medical education in
national languages. It was reemphasized to share knowledge on POCUS from these
Nations.
Medical
Students and Licensed Medical Doctors need different research educational training
standards and that would work to decrease interpersonal variability in data
collection.
Special
Remarks were delivered by Dr. Patanjali Dev Nayyar from WHO SEARO on important
aspects of strategies related to growing the use of POCUS in Medicine and health
facilities across India.
Featured
Research Presentation:
UTILITY OF LUS SCORING
SYSTEM DURING COVID-19 PANDEMIC
Presented By Dr. Sanjan. A Assistant Professor of Emergency Medicine, Kasturba Medical College, Manipal, India
The
COVID-19 pandemic, has affected healthcare systems around the globe, especially
in triaging and prioritizing patients for testing and isolation, especially
when dealing with atypical presentations. Computed
tomography (CT) scan of the chest is the imaging modality of choice.
Interstitial involvement was the main finding. Lung ultrasound (LUS) is an alternative to chest CT that
had gained popularity in the triage, diagnosis, and follow up and even to
prognosticate the COVID patient. Recent studies had shown the utility of LUS in
the diagnosis of COVID-19 that showed various findings ranging from A lines to
consolidation depending on the severity of the infection. In addition to this
LUS scoring system has gained popularity with score ranging from 0 to 36. Studies
have shown LUS could be used for strategizing the management plan of the
patients, could diagnose early VAP. Increase in LUS score had a relation with
severity of ARDS or worsening respiratory failure, whereas decrease in LUS had
been used to wean the patient from ventilator.
No comments:
Post a Comment